Physician

Melissa Asmar

According to 2025 Medicare claims, Melissa Asmar (NPI: 1487188124) practices epileptologists in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIV OF CA (NPI: 1356330203; TIN: 680334324) and primary practice location at 95817-2201.

Asmar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 189 traditional Medicare patients, billed 435 HCPCS/CPT codes, and received $39,938 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 275 prescription claims across 28 beneficiaries totaling $90,676 in drug costs, led by Lamotrigine Er (Lamotrigine). Open Payments data shows 2 records totaling $401. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,931 and ending at $90,676. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$40K2023 Medicare payment: $11,447 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $39,938 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202361100$11,447
2024189435$39,938

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$85K$170K2017 Drug cost: $2,931 (USD; Tot_Drug_Cst)2018 Drug cost: $34,842 (USD; Tot_Drug_Cst)2019 Drug cost: $169,700 (USD; Tot_Drug_Cst)2020 Drug cost: $82,748 (USD; Tot_Drug_Cst)2021 Drug cost: $34,906 (USD; Tot_Drug_Cst)2022 Drug cost: $3,420 (USD; Tot_Drug_Cst)2023 Drug cost: $29,483 (USD; Tot_Drug_Cst)2024 Drug cost: $90,676 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172979$2,931
201852158$34,842
201927137$169,700
202027155$82,748
202119115$34,906
20221247$3,420
20231749$29,483
202428275$90,676

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional65129$165
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2131$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2534$73
95816Measurement of brain wave activity (eeg), awake and drowsy4546$43
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's3450$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Lamotrigine ErLamotrigine241,477$7,871
LacosamideLacosamide20750$6,686
ClobazamClobazam33980$3,931
LevetiracetamLevetiracetam372,086$2,249
PhenobarbitalPhenobarbital11298$757

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$401LivaNova USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Melissa Asmar?

Tedicare shows public-source Medicare data for Melissa Asmar (NPI 1487188124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melissa Asmar have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Melissa Asmar?

Melissa Asmar is linked to REGENTS OF THE UNIV OF CA (billing NPI 1356330203) in the available physician profile data.

Does Melissa Asmar have Open Payments data?

Melissa Asmar has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.